awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47700645-128BB33B-0AC9-449A-8834-F3497B2EB643
Q47700645-128BB33B-0AC9-449A-8834-F3497B2EB643
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47700645-128BB33B-0AC9-449A-8834-F3497B2EB643
Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus.
P2860
Q47700645-128BB33B-0AC9-449A-8834-F3497B2EB643
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47700645-128BB33B-0AC9-449A-8834-F3497B2EB643
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4f55bc71326fad2319ba01bd3cf5a62fe511cca
P2860
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.